An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications
Clinical trial NCT02082249 · COMPLETED
Trial details
- NCT number
- NCT02082249
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-10
- Primary completion
- 2019-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.